KARD
Kardigan, Inc.
NASDAQ · Healthcare · Biotechnology · US
$20.85
+0.53%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−7.0x
Market Cap
$1.95B
MomentumView details →
1D Return
+0.53%
YTD Return
—
RSI (14)
49.9
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−7.0x
Market Cap
$1.95B
RSI (14)
49.9
MomentumView details →
1D Return
+0.53%
YTD Return
—
Similar companies
Latest newsMore news →
Kardigan, Inc. reported its financial results for the second quarter ended June 30, 2026.24d agoKardigan closed its initial public offering of 28,750,000 shares of common stock at $16.00 per share, raising $460 million in gross proceeds.74d agoKardigan Inc. raised $400 million in an upsized US initial public offering that priced at the top of its marketed range.79d ago